1. Home
  2. ABTS vs CELZ Comparison

ABTS vs CELZ Comparison

Compare ABTS & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • CELZ
  • Stock Information
  • Founded
  • ABTS 2010
  • CELZ 1998
  • Country
  • ABTS Hong Kong
  • CELZ United States
  • Employees
  • ABTS N/A
  • CELZ N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • CELZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABTS Technology
  • CELZ Health Care
  • Exchange
  • ABTS Nasdaq
  • CELZ Nasdaq
  • Market Cap
  • ABTS 4.6M
  • CELZ 5.5M
  • IPO Year
  • ABTS N/A
  • CELZ N/A
  • Fundamental
  • Price
  • ABTS $3.79
  • CELZ $2.02
  • Analyst Decision
  • ABTS
  • CELZ
  • Analyst Count
  • ABTS 0
  • CELZ 0
  • Target Price
  • ABTS N/A
  • CELZ N/A
  • AVG Volume (30 Days)
  • ABTS 366.3K
  • CELZ 34.9K
  • Earning Date
  • ABTS 12-31-2024
  • CELZ 05-09-2025
  • Dividend Yield
  • ABTS N/A
  • CELZ N/A
  • EPS Growth
  • ABTS N/A
  • CELZ N/A
  • EPS
  • ABTS N/A
  • CELZ N/A
  • Revenue
  • ABTS $6,711,225.00
  • CELZ $14,000.00
  • Revenue This Year
  • ABTS N/A
  • CELZ N/A
  • Revenue Next Year
  • ABTS N/A
  • CELZ N/A
  • P/E Ratio
  • ABTS N/A
  • CELZ N/A
  • Revenue Growth
  • ABTS 299.11
  • CELZ 55.56
  • 52 Week Low
  • ABTS $0.25
  • CELZ $1.69
  • 52 Week High
  • ABTS $4.19
  • CELZ $6.90
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 53.78
  • CELZ 44.81
  • Support Level
  • ABTS $2.91
  • CELZ $1.94
  • Resistance Level
  • ABTS $9.40
  • CELZ $2.20
  • Average True Range (ATR)
  • ABTS 1.01
  • CELZ 0.14
  • MACD
  • ABTS 0.03
  • CELZ 0.04
  • Stochastic Oscillator
  • ABTS 21.54
  • CELZ 40.00

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: